Launch of Indian public health standards for Ayush healthcare facilities
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
BHL will undertake the development and supply of these molecules
The plant will drive pharmaceutical innovation in the Northeastern India
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
Varenicline is indicated for smoking cessation in adults
Subscribe To Our Newsletter & Stay Updated